MT5502: Drug Development to Evidence Based Medicine

MT5502: DRUG DEVELOPMENT TO EVIDENCE BASED MEDICINE (2014-2015)

Last modified: 28 Jun 2018 10:27

Course Overview

None.

Course Details

Study Type	Postgraduate	Level	5
Term	Second Term	Credit Points	20 credits (10 ECTS credits)
Campus	None.	Sustained Study	No
Co-ordinators	Dr James McLay

What courses & programmes must have been taken before this course?

None.

What other courses must be taken with this course?

None.

What courses cannot be taken with this course?

None.

Are there a limited number of places available?

Course Description

Impact or particular disease states with reference to the pathophysiology, epidemiology, economic cost and current drugs available. Rationale for further drug development and clinical trials. End point measurements. Drug trial design. Critical analysis of 'key' publications on the treatment of disease. Clinical guidelines. Selecting a limited list of medicines. Pharmacovigilance. Ethics. Development of a new medicinal compound from pharmacology to pharmaceutical product.

Contact Teaching Time

Information on contact teaching time is available from the course guide.

Teaching Breakdown

More Information about Week Numbers

Details, including assessments, may be subject to change until 21st September 2026 for Term 1 and Full Year courses and 8th January 2027 for Term 2 courses.

Summative Assessments

2 assignments each comprising a presentation (2x 10%) and an essay (2x 25%) and 1 general essay (30%)

Formative Assessment

There are no assessments for this course.

Feedback

None.

Course Learning Outcomes

None.

51cg